FDA - McKnight's Long Term Care News


Clinical Briefs for Wednesday, Nov. 6

Single odds-defying case may lead to new Alzheimer’s treatments … Fully digital Alzheimer’s study to track risk factors in 400,000 volunteers … Blood samples may identify those at risk for frailty … FDA approves Talicia® for treatment of H. pylori in adults

CGM limits are said to set bad precedent

Despite the fact that the Food and Drug Administration approved its third continuous glucose monitoring device and incorporated a mobile app in March, Medicare beneficiaries still can’t take full advantage of this convenient technology because of a policy that also threatens to restrict coverage of future remote patient-monitoring technologies. At issue, experts say, is a…

Next post in Products